| |
|
Robert Franc
Director of Competitive Intelligence
Centocor
Robert Franc has over 26 years of Competitive Intelligence Experience; 12 years working for the US
Government and 14 years in the pharmaceutical industry. He has developed CI programs in the US,
Europe, Asia & the Middle East. During his 14 years in the pharmaceutical industry, he has supported R&D
and commercial organizations, both in the US & Europe.
Robert has spent the past 5 years as the Director for Competitive Intelligence for Centocor, a biotechnology
company in the Johnson & Johnson pharmaceutical business.
|
|
|
|
Monika Giese
Head of Global Competitive Intelligence
Novartis Pharma AG
Monika Giese is currently the Head of Global Competitive Intelligence at Novartis Pharma at their strategic
HQ in Switzerland.
Before working at Novartis, Monika worked for GSK, Solvay, IMS International and F.Hoffmann – La Roche.
Her experience ranges from information management via market research and business analytics to a
variety of functions in competitive intelligence.
Monika is a biologist by training, and also holds certified degrees in pharmacology, Information Science,
Market Research and Competitive Intelligence. She’s currently also a member of the Strategic Insights
Leadership Forum.
|
|
|
|
Craig McHenry
Senior Director, Competitor Insights
Wyeth
Craig joined Wyeth (formerly American Home Products Corporation) in 1991 and advanced his
understanding of the pharmaceutical industry while working in several business functions. He started in
Global Business Development and Licensing before moving to manage the Secondary Research Analysis
function. He has also worked in Marketing Research where he spent two years directing oncology and
hematology market research in the Wyeth BioPharma business unit. Since early in his career at Wyeth,
Craig has been involved with competitive intelligence. In 1993, Craig played a key role in forming the first
Business and Competitive Intelligence function, which has evolved over the years into the current group
that he directs called Competitor Insights. One of a handful of groups focused on specific analysis
techniques, this group provides CI consulting, expertise, and oversight to brand teams, new product groups,
and Senior Management. Before Wyeth, Craig spent five years at Unisys and holds a M.A. in Computer
Science Ed. He has been a member of SCIP since 1993 and is a graduate from the Gilead-Herring
Academy of Competitive Intelligence.
|
| |
|
Shacker Mourad
Director, Strategy Analysis and Intelligence
AstraZeneca Pharmaceuticals
Shacker is the Director of Competitive Intelligence for AstraZeneca US business.
Shacker’s 25 year pharmaceutical career spans the value chain in the US and abroad, where he worked in
Quality Assurance for Eli Lilly International, Sales for Schering Plough, Sales and Marketing, Clinical
Development and Intelligence for AstraZeneca and predecessor company AstraMerck.
He holds and MBA in Pharmaceutical Marketing from ST. Joseph’s University and holds Pharmacy Licenses
in Pennsylvania and New York. He stays current with the Pharmacy profession by continuing to practice as
an in-patient pharmacist in a hospital setting.
|
|
|
|
Dr. Daniel R. Pascheles
Vice President, Global Competitive Intelligence
Merck & Co., Inc.
Dr. Daniel R. Pascheles is Vice President, Global Competitive Intelligence, and is based in Whitehouse
Station NJ, at the Global HQ of Merck & Co., Inc.
His responsibilities include providing intelligence regarding business, research and development activities
of competitors, as well as participating in, and contribution to the strategy development process, the target
identification for licensing and M&A activities.
Pascheles joined Merck & Co., Inc. early 2005 from Aventis Inc. where he was Vice President and head of
Corporate Competitive Intelligence. He has worked for Aventis and its predecessor company (Hoechst
Marion Roussel, Marion Merrell Dow) for 14 years in various positions and locations.
Pascheles studied Pharmacy at the Swiss Federal Institute of Technology in Zurich, Switzerland. He
received his Ph.D. in Pharmaceutical Technology from the same university. He has done additional study
at the University of Kansas in Lawrence, Kansas.
Pascheles is Past-President and current Board member of the Pharmaceutical Business Intelligence &
Research Group (PBIRG). He is also member of the Society of Competitive Intelligence Professionals
(SCIP) and the Licensing Executive Society (LES).
|
|
|
|
Renee Pierson
Director of Global Business Intelligence
Johnson & Johnson Pharmaceutical Services
Renee Pierson was recently appointed as Global Intelligence Leader, internal medicine & virology at
Johnson & Johnson Pharmaceutical Services. Prior to this appointment, she was Director of Business
Intelligence for Ortho-McNeil Janssen Pharmaceutical Services.
She joined the Johnson & Johnson Family of Companies in 1996 as a Manager, Marketing Research for
New Products at Ortho-McNeil Pharmaceutical and has since moved to positions of increasing
responsibility within the pharmaceutical sector at Johnson & Johnson. Prior to her appointment to Business
Intelligence, she held the position of Group Director, Marketing Research & Forecasting.
Renee has over 20 years of experience in the Pharmaceutical Industry. In addition to Johnson & Johnson,
she held positions at Novartis and Sanofi Aventis in areas of Finance, Business Planning and Market
Research. She is past President and Board Member of the Pharmaceutical Marketing Research Group
(PMRG) and has served on the Editorial Board for the Journal of Pharmaceutical Marketing & Management.
Renee is also a member of the Society of Competitive Intelligence Professionals (SCIP).
|
|
|
|
Chandra Ramanathan
Director, Gobal Business and Competitive Intelligence
Bristol-Myers Squibb
Dr. Chandra Ramanathan has been associated with pharmacy academia and pharmaceutical industry for
more than 22 years. He has successfully applied scientific insights to address business issues in oncology,
immunology, Neuroscience and gastroenterology. He has extensive experience in Identifying new
licensing/business development opportunities and conducting scientific and commercial due diligence on
both compounds and technology deals. He has played a key role at Bristol-Myers Squibb in providing
scientific and commercial insights for strategic decision making and has contributed to oncology,
neuroscience and immunology portfolio planning.
Dr. Ramanathan has contributed to the launch of Orencia (Biologic; Rheumatoid arthritis) and Sprycel
(small molecule; Chronic Myelogenous Leukemia) by incorporating competitive insights in marketing
strategy development and execution. He has worked across the product development and
commercialization spectrum from discovery, clinical development to marketing. He has successfully worked
in new product planning/product commercialization and has contributed to the development of clinical
and commercial strategy for early and late-stage compounds. He also played a key role in evaluating
biosimilars for potential opportunities and assessing risk for the commercial franchise.
Dr. Ramanathan is currently the Director of Global Business and Competitive Intelligence group at BMS.
His team is responsible for providing competitive strategic insights for both marketed and developmental-
stage compounds. He has a broad pharmaceutical-based academic background with a Ph.D. in pharmacy
focusing on genomics, M.S. in medicinal chemistry and B.S. in pharmacy. He also has an M.B.A for the
Columbia Business School, New York.
Dr. Ramanathan’s scientific credentials include 80 filed patents with 18 issued to date, 2 book chapters, 12
publications and 34 presentations in scientific meetings.
|
|
|
|
Dawn Renear
Vice President, Competitive & Technical Information
Genzyme Corp.
Dawn Renear is Vice President of Competitive & Technical Information at Genzyme Corporation in
Cambridge, MA. She oversees two intelligence functions: Technical Intelligence and Competitive & Market
Intelligence. These groups are responsible for providing intelligence to all areas of the corporation, and are
fully integrated into both business and science teams.
Dawn is responsible for integrating intelligence activities into business processes and growing corporation
recognition of effective intelligence processes. Also under her responsibility is the Global Library group.
Prior to Genzyme, Dawn was Manager of Information Services at Integrated Genetics, Inc. and Analyst at
the Center for the Analysis of Health Practices, Harvard School of Public Health. Dawn has over 25 years of
experience in the biopharma industry. She holds a B.A. in Art History from the University of Massachusetts at
Amherst and M.S. in Information Science from Simmons College.
|
| |
|
Hu Song
Director, Business Information WW
Ethicon
a Johnson & Johnson company
|
|
|
|
Sue Ward
Director, Information and Knowledge Management
Pfizer Global Research & Development
Sue Ward is currently Director of Competitive Intelligence within Pfizer Global Research & Development.
Before working at Pfizer, Sue worked in the UK as Associate Director of Competitive Analysis for SmithKline
Beecham (SB) (now GlaxoSmithKline). Other positions held within SB’s R&D division included Manager of
a Clinical Information group and Manager of the Product Literature Information Service. Sue holds a BSc
(Hons) in Biology from University College, London and an MSc in Information Science from The City
University, London. Sue is a member of the Society of Competitive Intelligence Professionals (SCIP).
|
|
